Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 360

1.

Immunoregulatory impact of human mesenchymal-conditioned media and mesenchymal derived exosomes on monocytes.

Tokhanbigli S, Baghaei K, Asadirad A, Hashemi SM, Asadzadeh-Aghdaei H, Zali MR.

Mol Biol Res Commun. 2019 Jun;8(2):79-89. doi: 10.22099/mbrc.2019.33346.1397.

PMID:
31531379
2.

Lack of health care professional's awareness for management of celiac disease may contribute to the under diagnosis of celiac disease.

Barzegar F, Rostami-Nejad M, Rostami K, Ahmadi S, Mohaghegh Shalmani H, Sadeghi A, Allahverdi Khani M, Aldulaimi D, Zali MR.

Gastroenterol Hepatol Bed Bench. 2019 Summer;12(3):203-208.

PMID:
31528303
3.

Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis.

Morshedzadeh N, Shahrokh S, Aghdaei HA, Amin Pourhoseingholi M, Chaleshi V, Hekmatdoost A, Karimi S, Zali MR, Mirmiran P.

Complement Ther Med. 2019 Oct;46:36-43. doi: 10.1016/j.ctim.2019.07.012. Epub 2019 Jul 19.

PMID:
31519285
4.

Investigating the TLR9 mRNA Expression Level in Different Histological Types of Colorectal Polyps.

Rezasoltani S, Khatibi S, Pezeshkiyan Z, Nazemalhosseini-Mojarad E, Sharafkhah M, Sadeghi A, Asadzadeh Aghdaei H, Zali MR.

Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2299-2302. doi: 10.31557/APJCP.2019.20.8.2299.

5.

Conditioned Medium from Cultured Colorectal Cancer Cells Affects Peripheral Blood Mononuclear Cells Inflammatory Phenotype in Vitro.

Mohebbi B, Ashtibaghaei K, Hashemi M, Hashemi M, Asadzadeh Aghdaei H, Zali MR.

Iran J Med Sci. 2019 Jul;44(4):334-341. doi: 10.30476/IJMS.2019.44959.

6.

Letter to the Editor: Activated Toxoplasma May Attenuate the Effect of Azathioprine and Deteriorate the Symptoms in IBD Patients via mTORC1 Manipulation.

Mirjalali H, Shahrokh S, Asadzadeh Aghdaei H, Zali MR.

Inflamm Bowel Dis. 2019 Jul 13. pii: izz161. doi: 10.1093/ibd/izz161. [Epub ahead of print] No abstract available.

PMID:
31300821
7.

Blastocystis subtype 1 (allele 4); Predominant subtype among tuberculosis patients in Iran.

Taghipour A, Javanmard E, Mirjalali H, Haghighi A, Tabarsi P, Sohrabi MR, Zali MR.

Comp Immunol Microbiol Infect Dis. 2019 Aug;65:201-206. doi: 10.1016/j.cimid.2019.06.005. Epub 2019 Jun 13.

PMID:
31300114
8.

YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.

Bjeije H, Soltani BM, Behmanesh M, Zali MR.

Hum Mol Genet. 2019 Jun 25. pii: ddz146. doi: 10.1093/hmg/ddz146. [Epub ahead of print]

PMID:
31238337
9.

The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease.

Haghbin M, Rostami-Nejad M, Forouzesh F, Sadeghi A, Rostami K, Aghamohammadi E, Asadzadeh-Aghdaei H, Masotti A, Zali MR.

Medicine (Baltimore). 2019 Jun;98(25):e15949. doi: 10.1097/MD.0000000000015949.

10.

Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran.

Azimirad M, Gholami F, Yadegar A, Knight DR, Shamloei S, Aghdaei HA, Zali MR.

Sci Rep. 2019 May 24;9(1):7792. doi: 10.1038/s41598-019-44281-5.

12.

Decreased miR-155-5p, miR-15a, and miR-186 Expression in Gastric Cancer Is Associated with Advanced Tumor Grade and Metastasis

Zare A, Alipoor B, Omrani MD, Zali MR, Malekpour Alamdari N, Ghaedi H.

Iran Biomed J. 2019 Sep;23(5):338-343. Epub 2019 May 19.

13.

V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease.

Asadzadeh-Aghdaei H, Mashayekhi K, Koushki K, Azimzadeh P, Rostami-Nejad M, Amani D, Chaleshi V, Haftcheshmeh SM, Sahebkar A, Zali MR.

J Cell Biochem. 2019 Sep;120(9):15746-15755. doi: 10.1002/jcb.28844. Epub 2019 May 8.

PMID:
31069840
14.

Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.

Lotfinia M, Abdollahpour-Alitappeh M, Hatami B, Zali MR, Karimipoor M.

Clin Exp Med. 2019 Aug;19(3):289-298. doi: 10.1007/s10238-019-00557-8. Epub 2019 May 3. Review.

PMID:
31054018
15.

Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.

Gharib E, Anaraki F, Baghdar K, Ghavidel P, Sadeghi H, Nasrabadi PN, Peyravian N, Aghdaei HA, Zali MR, Mojarad EN.

J Cell Biochem. 2019 Sep;120(9):14780-14790. doi: 10.1002/jcb.28739. Epub 2019 Apr 16.

PMID:
30993787
16.

Bioburden and transmission of pathogenic bacteria through elevator channel during endoscopic retrograde cholangiopancreatography: application of multiple-locus variable-number tandem-repeat analysis for characterization of clonal strains.

Azimirad M, Alebouyeh M, Sadeghi A, Khodamoradi E, Aghdaei HA, Mohammad Alizadeh AH, Zali MR.

Expert Rev Med Devices. 2019 May;16(5):413-420. doi: 10.1080/17434440.2019.1604215. Epub 2019 Apr 22.

PMID:
30957585
17.

A gene variation of Interferon Gamma Receptor-I promoter (rs1327474A>G) and chronic hepatitis C virus infection.

Karkhane M, Mohebbi SR, Sharifian A, Ghaemi A, Asadzadeh Aghdaei H, Zali MR.

Gastroenterol Hepatol Bed Bench. 2019 Winter;12(1):46-51.

18.

Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.

Azimirad M, Azizi O, Alebouyeh M, Aslani MM, Mousavi SF, Zali MR.

Infect Genet Evol. 2019 Jul;71:205-210. doi: 10.1016/j.meegid.2019.03.010. Epub 2019 Mar 19.

PMID:
30902742
19.
20.

Prevalence of gluten-related disorders in Asia-Pacific region: a systematic review.

Ashtari S, Pourhoseingholi MA, Rostami K, Aghdaei HA, Rostami-Nejad M, Busani L, Tavirani MR, Zali MR.

J Gastrointestin Liver Dis. 2019 Mar;28(1):95-105. doi: 10.15403/jgld.2014.1121.281.sys.

21.

Barrett's esophagus network analysis revealed that arginine, alanine, aspartate, glutamate, valine, leucine and isoleucine can be biomarkers.

Zali MR, Zadeh-Esmaeel MM, Rezaei Tavirani M, Rezaei Tavirani S, Norouzinia M, Rezaei-Tavirani M.

Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S98-S104.

22.

Barrett's esophagus transits to a cancer condition via potential biomarkers.

Zali MR, Zadeh-Esmaeel MM, Rezaei-Tavirani M, Sadat Tabatabaei E, Ali Ahmadi N.

Gastroenterol Hepatol Bed Bench. 2018 Winter;11(Suppl 1):S80-S84.

23.

A detailed image of rutin underlying intracellular signaling pathways in human SW480 colorectal cancer cells based on miRNAs-lncRNAs-mRNAs-TFs interactions.

Nasri Nasrabadi P, Zareian S, Nayeri Z, Salmanipour R, Parsafar S, Gharib E, Asadzadeh Aghdaei H, Zali MR.

J Cell Physiol. 2019 Jan 29. doi: 10.1002/jcp.28204. [Epub ahead of print]

PMID:
30697726
24.

Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction.

Heidarian F, Alebouyeh M, Shahrokh S, Balaii H, Zali MR.

Curr Res Transl Med. 2019 May;67(2):41-50. doi: 10.1016/j.retram.2019.01.002. Epub 2019 Jan 23.

PMID:
30685379
25.

Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population.

Shoraka S, Mohebbi SR, Hosseini SM, Hosseini Razavi A, Hatami Y, Sharifian A, Rostami-Nejad M, Asadzadeh Aghdaei H, Zali MR.

Microb Pathog. 2019 Mar;128:263-267. doi: 10.1016/j.micpath.2019.01.008. Epub 2019 Jan 10.

PMID:
30639626
26.

Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.

Nazemalhosseini-Mojarad E, Kishani Farahani R, Mehrizi M, Baghaei K, Yaghoob Taleghani M, Golmohammadi M, Peyravian N, Ashtari S, Pourhoseingholi MA, Asadzadeh Aghdaei H, Zali MR.

J Gastrointest Cancer. 2019 Jan 12. doi: 10.1007/s12029-019-00201-4. [Epub ahead of print]

PMID:
30635874
27.

Phenotypical and functional evaluation of dendritic cells after exosomal delivery of miRNA-155.

Asadirad A, Hashemi SM, Baghaei K, Ghanbarian H, Mortaz E, Zali MR, Amani D.

Life Sci. 2019 Feb 15;219:152-162. doi: 10.1016/j.lfs.2019.01.005. Epub 2019 Jan 6.

PMID:
30625290
28.

The relationship between 174 G/C and -572 G/C of IL-6 gene polymorphisms and susceptibility of celiac disease in the Iranian population.

Barartabar Z, Nikzamir A, Sirati-Sabet M, Aghamohammadi E, Chaleshi V, Nejad MR, Asadzadeh-Aghdaei H, Reza Zali M.

Prz Gastroenterol. 2018;13(4):293-298. doi: 10.5114/pg.2018.79808. Epub 2018 Dec 11.

29.

HER2+ mCRC patients with exon 20 R784G substitution mutation do not respond to the cetuximab therapy.

Gharib E, Salmanipour R, Nazemalhosseini Mojarad E, Yaghoob Taleghani M, Sarlak S, Malekzade-Moghani M, Nasrabadi PN, Meiary MA, Asadzadeh Aghdaei H, Zali MR.

J Cell Physiol. 2019 Aug;234(8):13137-13144. doi: 10.1002/jcp.27984. Epub 2018 Dec 13.

PMID:
30549033
30.

Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces.

Shojaee S, Hajizadeh N, Najafimehr H, Busani L, Pourhoseingholi MA, Baghestani AR, Nasserinejad M, Ashtari S, Zali MR.

PLoS One. 2018 Dec 13;13(12):e0199273. doi: 10.1371/journal.pone.0199273. eCollection 2018.

31.

Interleukin 12B mRNA level and rs3212227 genotyping in peripheral blood mononuclear cells of inflammatory bowel disease patients

Aghdae HA, Emami E, Nourian M, Chaleshi V, Tarban P, Balaii H, Azimzadeh P, Irani S, Shahrokh S, Rostami-Nejad M, Zali MR.

Turk J Med Sci. 2018 Dec 12;48(6):1147-1152. doi: 10.3906/sag-1711-136.

PMID:
30541240
32.

Exosomes as a novel cell-free therapeutic approach in gastrointestinal diseases.

Baghaei K, Tokhanbigli S, Asadzadeh H, Nmaki S, Reza Zali M, Hashemi SM.

J Cell Physiol. 2019 Jul;234(7):9910-9926. doi: 10.1002/jcp.27934. Epub 2018 Dec 7. Review.

PMID:
30536895
33.

Can Giardia Infection Impair the Diagnostic Level of Fecal Calprotectin in Patients with Inflammatory Bowel Disease? A Case Report.

Mohammad Ali Gol S, Mirjalali H, Asadzadeh Aghdaei H, Zali MR.

Iran J Parasitol. 2018 Jul-Sep;13(3):505-509.

34.

Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes.

Abdollahpour-Alitappeh M, Lotfinia M, Gharibi T, Mardaneh J, Farhadihosseinabadi B, Larki P, Faghfourian B, Sepehr KS, Abbaszadeh-Goudarzi K, Abbaszadeh-Goudarzi G, Johari B, Zali MR, Bagheri N.

J Cell Physiol. 2019 May;234(5):5628-5642. doi: 10.1002/jcp.27419. Epub 2018 Nov 27. Review.

PMID:
30478951
35.

Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.

Rezasoltani S, Sharafkhah M, Asadzadeh Aghdaei H, Nazemalhosseini Mojarad E, Dabiri H, Akhavan Sepahi A, Modarressi MH, Feizabadi MM, Zali MR.

J Microbiol Methods. 2018 Dec;155:82-88. doi: 10.1016/j.mimet.2018.11.007. Epub 2018 Nov 12.

PMID:
30439465
36.

A rare presentation of simple renal cyst: gastrointestinal obstruction.

Sadeghi A, Shahrbaf MA, Asadzadeh Aghdaei H, Esmaeilinejad K, Zali MR.

Gastroenterol Hepatol Bed Bench. 2018 Fall;11(4):359-362.

37.

Small-scale risk assessment of transmission of parasites from wastewater treatment plant to downstream vegetable farms.

Javanmard E, Mirjalali H, Niyyati M, Sharifdini M, Jalilzadeh E, Seyed Tabaei SJ, Asadzadeh Aghdaei H, Rostami R, Nazemalhosseini-Mojarad E, Haghighi A, Zali MR.

Gastroenterol Hepatol Bed Bench. 2018 Fall;11(4):352-358.

38.

Contribution of HLA-DQ2/DQ8 haplotypes in type one diabetes patients with/without celiac disease.

Moheb-Alian A, Forouzesh F, Sadeghi A, Rostami K, Aghamohammadi E, Rostami-Nejad M, Rezaei-Tavirani M, Zali MR.

J Diabetes Complications. 2019 Jan;33(1):59-62. doi: 10.1016/j.jdiacomp.2018.10.001. Epub 2018 Oct 25.

PMID:
30415877
39.

miR-30a promoter variation contributes to the increased risk of colorectal cancer in an Iranian population.

Sadeghi H, Nazemalhosseini-Mojarad E, Yaghoob-Taleghani M, Amin-Beidokhti M, Yassaee VR, Aghdaei HA, Zali MR, Mirfakhraie R.

J Cell Biochem. 2018 Nov 1. doi: 10.1002/jcb.28047. [Epub ahead of print]

PMID:
30387187
40.

Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.

Nazemalhosseini-Mojarad E, Mohammadpour S, Torshizi Esafahani A, Gharib E, Larki P, Moradi A, Amin Porhoseingholi M, Asadzade Aghdaei H, Kuppen PJK, Zali MR.

J Cell Physiol. 2019 Apr;234(4):4768-4777. doi: 10.1002/jcp.27273. Epub 2018 Oct 28.

PMID:
30370522
41.

Lack of Association between Interleukin 23R (IL-23R) rs10889677 Polymorphism and Inflammatory Bowel Disease Susceptibility In an Iranian Population.

Karimkhani S, Chaleshi V, Balaii H, Tarban P, Nourian M, Irani S, Shahrokh S, Asadzadeh Aghdaei H, Mohammad Alizadeh AH, Norouzinia M, Zali MR.

Rep Biochem Mol Biol. 2018 Oct;7(1):16-22.

42.

Serum cytokines profile in treated celiac disease compared with non-celiac gluten sensitivity and control: a marker for differentiation.

Heydari F, Rostami-Nejad M, Moheb-Alian A, Mollahoseini MH, Rostami K, Pourhoseingholi MA, Aghamohammadi E, Zali MR.

J Gastrointestin Liver Dis. 2018 Sep;27(3):241-247. doi: 10.15403/jgld.2014.1121.273.hey.

43.

An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients.

Aghdaei HA, Kadijani AA, Sorrentino D, Mirzaei A, Shahrokh S, Balaii H, Geraci M, Zali MR.

United European Gastroenterol J. 2018 Aug;6(7):1074-1081. doi: 10.1177/2050640618774637. Epub 2018 May 2.

44.

Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.

Azizmohammad Looha M, Pourhoseingholi MA, Nasserinejad M, Najafimehr H, Zali MR.

Epidemiol Health. 2018;40:e2018045. doi: 10.4178/epih.e2018045. Epub 2018 Sep 17.

45.

Analysis of IL17A and IL21 Expression in the Small Intestine of Celiac Disease Patients and Correlation with Circulating Thioredoxin Level.

Faghih M, Rostami-Nejad M, Amani D, Sadeghi A, Pourhoseingholi MA, Masotti A, Zali MR.

Genet Test Mol Biomarkers. 2018 Sep;22(9):518-525. doi: 10.1089/gtmb.2018.0128. Epub 2018 Sep 5.

PMID:
30183349
46.

The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.

Zare A, Ahadi A, Larki P, Omrani MD, Zali MR, Alamdari NM, Ghaedi H.

Mol Biol Rep. 2018 Dec;45(6):1587-1595. doi: 10.1007/s11033-018-4278-5. Epub 2018 Aug 31.

PMID:
30171475
47.

Investigation of adherent-invasive E. coli in patients with Crohn's disease.

Sarabi Asiabar A, Asadzadeh Aghdaei H, Sabokbar A, Zali MR, Feizabadi MM.

Med J Islam Repub Iran. 2018 Feb 11;32:11. doi: 10.14196/mjiri.32.11. eCollection 2018.

48.

Characterization of clarithromycin heteroresistance among Helicobacter pylori strains isolated from the antrum and corpus of the stomach.

Farzi N, Behzad C, Hasani Z, Alebouyeh M, Zojaji H, Zali MR.

Folia Microbiol (Praha). 2019 Mar;64(2):143-151. doi: 10.1007/s12223-018-0637-9. Epub 2018 Aug 10.

PMID:
30097895
49.

Diverse Profiles of Toll-Like Receptors 2, 4, 7, and 9 mRNA in Peripheral Blood and Biopsy Specimens of Patients with Celiac Disease.

Ghasiyari H, Rostami-Nejad M, Amani D, Rostami K, Pourhoseingholi MA, Asadzadeh-Aghdaei H, Zali MR.

J Immunol Res. 2018 Jul 2;2018:7587095. doi: 10.1155/2018/7587095. eCollection 2018.

50.

A rapid and sensitive assay to identify HLA-DQ2/8 risk alleles for celiac disease using real-time PCR method.

Mashayekhi K, Rostami-Nejad M, Amani D, Rezaei-Tavirani M, Mohaghegh-Shalmani H, Zali MR.

Gastroenterol Hepatol Bed Bench. 2018 Summer;11(3):250-258.

Supplemental Content

Loading ...
Support Center